Daiichi Sankyo

The Daiichi Sankyo group is actively engaged in various measures and initiatives such as, but not limited to, contributing to vaccination and drug research and ... "; contents+=addScript; } } } returncontents; } }); })(jQuery); //--> "; contents+=addScript; } } } returncontents; } }); })(jQuery); //--> toContents,本文へ PassionforInnovation. CompassionforPatients. Notice Aug.22,2022 DaiichiSankyo‘sMedicinesarrivedathospitalsandotherlocationsinUkraine Jun.28,2022 DaiichiSankyodiscloseditsSlaveryandHumanTraffickingStatementforFiscalYear2021 Jun.14,2022 DaiichiSankyo'sJapanResearchFoundationforClinicalPharmacology15thAnnualClinicalPharmacologyResearchAwardwasannounced Specificinitiatives Specificinitiatives OurCompany’sEffortstoLimittheSpreadoftheVirusthatCausesCOVID-19 TheDaiichiSankyogroupisactivelyengagedinvariousmeasuresandinitiativessuchas,butnotlimitedto,contributingtovaccinationanddrugresearchanddevelopment,ensuringacontinuoussupplyofDaiichiSankyogroupcompanyproducts,andprovidingdisasterreliefsupport. ViewMore